Movement Disorders · 2004 · 55 citations · 8 references
MedicineNeurologyPharmacologyClinical NeuroscienceCognitive NeurologyNeuropharmacologyCholinergic PharmacologyHuntington DiseaseNeurodegenerative Disease PharmacologyNeurodegenerative Disease PharmacotherapyNeurodegenerative DiseasesNeurodegenerative DisordersCholinergic AgonistsCholinergic CircuitsCognitive PerformanceCognitive Performance ImpairmentHuntington Disease PharmacotherapyHuntington's Disease CognitionHuntington's Disease PharmacotherapyTreatment Of Cognitive Symptoms
To evaluate the efficacy of rivastigmine on motor and cognitive impairment in Huntington's disease (HD), we carried out a prospective, open-label, randomized, controlled study. Twenty-one HD patients were enrolled: 14 were randomly sorted into medication and 7 to no-treatment groups. Clinical and demographic features were similar between groups. After 8 months, an efficacy evaluation was carried out to compare the two groups. The improvement of cholinergic transmission in HD patients seemed to have a slight effect in ameliorating cognitive performance and slowing motor deterioration.
8
NEUROCHEMICAL ALTERATIONS IN HUNTINGTON'S CHOREA
E.G. Spokes · Brain · 1980 · 286 citations
Ira Shoulson · Neurology · 1981 · 232 citations